The cornerstone of reproductive fitness is the ability to generate functional haploid germ cells. One of the most common causes of male factor infertility is abnormal germ cell differentiation resulting in azoospermia or oligospermia. In females, the most common cause of infertility involves ovulatory dysfunction, with one important category being the quality and quantity of the oocyte reserve. Evaluating the molecular events involved in establishing the oocyte reserve and formation of spermatogonial stem cells is challenging because these events are completed before birth. Therefore, understanding early germ cell differentiation requires the establishment and validation of new and innovative laboratory models that begin at the embryonic stage. One of the most promising, yet still emerging technologies aimed at directly addressing germ cell differentiation involves the use of pluripotent stem cells to generate germ cells in vitro (Fig. 1) .
The initial studies describing germ cell differentiation from human pluripotent stem cells, including embryonic stem cells (ESCs) derived from the inner cell mass of human blastocysts and human induced pluripotent stem cells derived by reprogramming skin fibroblasts to a pluripotent state, resulted in the generation of fetal premeiotic-stage germ cells (Fig. 1 ) [1] [2] [3] [4] [5] [6] . However, in the October 28, 2009, advanced online edition of the Journal Nature, Kee and colleagues [7] describe a method for generating haploid germ cells from human male and female ESCs by overexpressing critical members of the deleted in azoospermia (DAZ) family, including DAZ-LIKE (DAZL) and BOLL (BOULE). The authors discovered that in male ESCs, overexpression of the Y-chromosome-specific gene DAZ together with DAZL and BOLL were required for generating 2% of cells with 1N (haploid) status. These in vitroderived germ cells offer the first promising glimpse at the future possibility of generating germ cells in culture that could be used to understand germ cell development, as well as a potential new avenue to treat infertility. These haploid germ cells will never be used in their current form as a therapy because genetic modification and random insertion of genes were used to facilitate the process of germ cell maturation in vitro [7] . Furthermore, if the therapeutic goal is to create germ cells that are genetically related to the future parent, then starting with induced pluripotent stem (IPS) cells instead of ESCs is the current option. However, with this new and important advance it is now time to begin a meaningful dialogue on the future of this technology, beginning with the ability to test the functional quality of these in vitro-derived haploid germ cells and the establishment of robust preclinical animal models. Recommendations such as these are outlined in the consensus statement on ''Science, Ethics and Policy Challenges of Pluripotent Stem Cell-Derived Gametes'' from the Hinxton Group (www.hinxtongroup.org), which was published verbatim in Biology of Reproduction [8] .
How Does A Scientist Test the Functionality of a Potential Human Male Haploid Gamete?
The only true test is the ability to demonstrate that the male gamete is capable of: 1) fertilizing an oocyte, 2) supporting embryo development, and 3) ultimately creating healthy, fertile offspring. Because of the ethical sensitivity of these studies with human cells, a prominent role for animal models using murine ESCs or IPS cells is required. However, animal modeling alone cannot be used exclusively to build and test the technology of in vitro germ cell differentiation, because it is clear that human reproduction uses divergent molecular pathways [9, 10] . Therefore, it is of critical importance to develop and improve animal models, such as the work described in the current issue of Biology of Reproduction [11] , in partnership with the human cell-based models to generate a functional haploid gamete in vitro.
Attempts to derive functional gametes from murine ESCs have resulted in poor functional quality, causing prenatal and postnatal demise when fertilized [12] . This has lead to a resurgence of studies aimed at more careful evaluation of the first steps involved in generating germ cells in vitro, specifically the formation of primordial germ cells (PGCs; Fig. 1 ). In this issue of Biology of Reproduction, a method for generating murine PGCs using a transgenic POU5F1 (Oct4)-GFP ESC reporter line is described [11] . Differentiation was conducted using the embryoid body (EB) method in media containing serum and bone morphogenetic protein 2 (BMP2) and BMP4. This resulted in 4%-5% of the EB population being identified as PGCs. This work constitutes one in an important collection of recent independent studies that reproducibly describe PGC differentiation from murine ESCs, and it consistently quantifies PGC formation in the 5% range [13] [14] [15] [16] [17] [18] . The results of Young et al. [11] also hint at the idea that erasure of DNA methylation from differentially methylated regions of imprinted genes requires exposure to a gonadal environment, and the ESC model could be used to address this idea in future work.
Robust PGC differentiation as reported by Young et al.
[11] required supplementation with BMP2 and BMP4 but not BMP8B, indicating that BMP8B is dispensable for PGC formation in culture. However, it is important to note that not every murine ESC line or differentiation strategy requires the addition of BMPs to consistently promote PGC differentiation [13, 16] . The reason why different ESC lines have different responsiveness to exogenous BMPs remains to be determined. However, differentiation media formulations seem to play an important role, as shown in a study using the Stella-GFP ESC reporter line [13] , which confirmed that differentiation in chemically defined media requires BMP2 or BMP4 and not BMP8B to restore PGC formation to ;5% of the EB population normally obtained when medium containing serum is used.
In conclusion, the study of Young et al. [11] in the context of recent studies on PGC specification from murine ESCs [13] [14] [15] [16] [17] substantially strengthens the utility and power of pluripotent stem cells as a model to understand molecular events required for PGC formation and sets a foundation from which to build the later stages of germ cell development that culminate in the creation of a functional haploid gamete. In the future, we need to take a deliberate and step-wise approach in figuring out how to induce PGCs to undergo faithful differentiation into more mature stages (Fig. 1 ). This includes a critical eye toward meiosis, recombination, and generation of accurate tests to ensure functional gamete quality. The recent remarkable achievement from Ohinata et al. [19] in which functional germ cells were derived in vitro from cultured epiblast cells indicates that the future of this technology as a potential option for treating infertility could be fast approaching.
